Select clinical trials of erlotinib (OSI-774) in non–small-cell lung cancer with emphasis on phase III outcomes

LMB Fuster, AB Sandler - Clinical lung cancer, 2004 - Elsevier
Lung cancer is primarily diagnosed during the advanced stage of disease, at which stage
treatment options are severely limited. It is primarily for this reason that lung cancer carries a …
被引用次数：84 相关文章

Select clinical trials of erlotinib (OSI-774) in non-small-cell lung cancer with emphasis on phase III outcomes

LMB Fuster, AB Sandler - Clinical lung cancer, 2004 - pubmed.ncbi.nlm.nih.gov
Lung cancer is primarily diagnosed during the advanced stage of disease, at which stage
treatment options are severely limited. It is primarily for this reason that lung cancer carries a …

Select Clinical Trials of Erlotinib (OSI-774) in Non–Small-Cell Lung Cancer with Emphasis on Phase III Outcomes

LMB Fuster, AB Sandler - Clinical Lung Cancer, 2004 - infona.pl
Lung cancer is primarily diagnosed during the advanced stage of disease, at which stage
treatment options are severely limited. It is primarily for this reason that lung cancer carries a …

Select Clinical Trials of Erlotinib (OSI-774) in Non–Small-Cell Lung Cancer with Emphasis on Phase III Outcomes

LMB Fuster, AB Sandler - Clinical Lung Cancer, 2004 - clinical-lung-cancer.com
Lung cancer is primarily diagnosed during the advanced stage of disease, at which stage
treatment options are severely limited. It is primarily for this reason that lung cancer carries a …

Select clinical trials of erlotinib (OSI-774) in non-small-cell lung cancer with emphasis on phase III outcomes.

LM Fuster, AB Sandler - Clinical Lung Cancer, 2004 - europepmc.org
Lung cancer is primarily diagnosed during the advanced stage of disease, at which stage
treatment options are severely limited. It is primarily for this reason that lung cancer carries a …